Neurotrack functions as a computer-based memory test that looks at impairments in the hippocampus of the brain, which is the first structure that is impacted by Alzheimer’s disease. It works as follows: Patients sit in front of a computer screen with an eye-tracking device and view a series of images, some novel and some not novel. Based on how much time a patient spends looking at the novel image versus the image that hasn’t changed, Neurotrack can give you a prognosis.
According to Kaplan, “It is a seemingly simple test that brings together two very complex things: First, a human being’s innate preference for novelty; and second, the discovery, made by Dr. Stuart Zola, that by tracking the way an individual moves their eyes, particularly when viewing objects or images, one is able to diagnose impairments that exist in the brain that might not be diagnosable by even more invasive diagnostic tools.”
What are the advantages of an early diagnosis of Alzheimer’s, a currently incurable disease?
- Finding the right people for clinical trials: One of the biggest problems that pharmaceutical companies face today in terms of developing preventive drugs for Alzheimer’s disease is populating the clinical trials with the right type of people. Neurotrack will help pharmaceutical companies find the right subjects for the trials, so they can be conducted more quickly, and life-saving drugs could get to market much faster.
- Families have an extra few years to plan financially for Alzheimer’s: The costs of Alzheimers disease are $200 billion today and projected to be in excess of $1 trillion by 2050. Families with loved ones who have Alzheimer’s often spend $10-$12,000 per month for nursing homes in Northern Virginia. An early diagnosis will enable the person with Alzheimer’s and his or her family to proactively meet with a Certified Elder Law Attorney, such as Evan Farr, and plan for future financial and long-term care needs.
To date, Neurotrack has received $50,000 in state grants from the Georgia Research Alliance. Emory University received approximately $2.3 million in funding from the National Institutes of Health and the Woodruff Foundation to support the scientific research behind Neurotrack’s diagnostic tests. The Atlanta-based startup, which launched over the summer, is currently raising a seed round of $1.5 million to $2.5 million from strategic and institutional investors.
Do you have a loved one who is suffering from Alzheimer’s? Persons with Alzheimer’s and their families face special legal and financial needs. At The Fairfax and Fredericksburg Medicaid Asset Protection Planning Law Firm of Evan H. Farr, P.C., we are dedicated to easing the financial and emotional burden on those suffering from Alzheimer’s and their loved ones. If you have a loved one who is suffering from Alzheimer’s, we can help you prepare for your future and for your loved ones. We help protect the family’s hard-earned assets while maintaining your loved one’s comfort, dignity, and quality of life by ensuring eligibility for critical government benefits. Call 703-691-1888 to make an appointment for a complimentary consultation.